Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.43 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1115950 | 1.00 | ACE2 (0.53) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL1115951 | 1.00 | ACE2 (0.53) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL1116127 | 1.00 | ACE2 (0.53) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL22555576 | 1.00 | ACE2 (0.53) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL22555398 | 1.00 | ACE2 (0.53) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL23494340 | 0.98 | ACE2 (0.50) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL3626573 | 0.93 | ACHE (0.47) | ACE2MAPTHCAR2PTPN1 | |
| SCHEMBL4199498 | 0.93 | ACHE (0.47) | ACE2MAPTHCAR2PTPN1 | |
| SCHEMBL4199497 | 0.93 | ACHE (0.47) | ACE2MAPTHCAR2PTPN1 | |
| SCHEMBL3626575 | 0.93 | ACHE (0.47) | ACE2MAPTHCAR2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119855607-A | Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application | 太阳雨林(北京)生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| WO-2023213310-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2023-11-09 | — | — | WO | disclosed |
| US-20230201275-A1 | RECOMBINANT BACTERIA PRODUCING CHEMICALS INHIBITORY TO SALMONELLA INVASION | CORNELL UNIVERSITY (US) | 2023-06-29 | — | — | US | disclosed |
| US-20230142090-A1 | COMPOSITIONS AND METHODS FOR INHIBITING VIBRIO INFECTION | CORNELL UNIVERSITY | 2023-05-11 | — | — | US | disclosed |
| EP-4126809-A2 | COMPOSITIONS AND METHODS FOR INHIBITING VIBRIO INFECTION | Cornell University (US) | 2023-02-08 | — | — | EP | disclosed |
| EP-4126914-A2 | RECOMBINANT BACTERIA PRODUCING CHEMICALS INHIBITORY TO SALMONELLA INVASION | Cornell University (US) | 2023-02-08 | — | — | EP | disclosed |
| CN-115607677-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-114569726-B | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-10-28 | — | — | CN | disclosed |
| US-20010038928-A1 | Magnetic recording media | NAKAMIGAWA JUNICHI (JP) | 2001-11-08 | — | — | US | disclosed |
| US-6291052-B1 | Magnetic recording medium | FUJI PHOTO FILM CO., LTD. (JP) | 2001-09-18 | — | — | US | disclosed |
| US-6254964-B1 | Magnetic recording medium | FUJI PHOTO FILM CO., LTD. (JP) | 2001-07-03 | — | — | US | disclosed |
| US-6124013-A | COMPRISING A MAGNETIC LAYER HAVING FERROMAGNETIC POWDER AND A BINDER DISPERSED THEREIN, SAID MAGNETIC LAYER BEING PROVIDED ON A NON-MAGNETIC SUPPORT, WHEREBY SAID MAGNETIC LAYER CONTAINS A DIESTER COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 2000-09-26 | — | — | US | disclosed |
| EP-0962919-A1 | MAGNETIC RECORDING MEDIUM | Fuji Photo Film Co., Ltd. (JP) | 1999-12-08 | — | — | EP | disclosed |
| EP-0889464-A2 | Magnetic recording medium | FUJI PHOTO FILM CO., LTD. (JP) | 1999-01-07 | — | — | EP | disclosed |
| EP-0865034-A1 | Magnetic recording medium | FUJI PHOTO FILM CO., LTD. (JP) | 1998-09-16 | — | — | EP | disclosed |
| US-5700541-A | DURABILITY, RUNNING PROPERTIES | FUJI PHOTO FILM CO., LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
| US-4915864-A | CARBOXYLIC ACID OR SALTS THEREOF AS SOLUBILIZING AGENT WETTING AGENT FOR GLASS, FIBERS, METALS | KAO CORPORATION (JP) | 1990-04-10 | — | — | US | disclosed |
| EP-0296432-A2 | Aqueous solution composition of strong alkali and nonionic surface active agent | Kao Corporation (JP) | 1988-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142090-A1 | COMPOSITIONS AND METHODS FOR INHIBITING VIBRIO INFECTION | FASN, VGF, PLA2G2F | ACE2 703/4885GPR84 2422/4885FFAR1 53/4885 |
| US-20230201275-A1 | RECOMBINANT BACTERIA PRODUCING CHEMICALS INHIBITORY TO SALMONELLA INVASION | SRRT, RAC1, BLVRB | ACE2 4101/4885GPR84 3950/4885FFAR1 2846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.